Renee de Waal
Overview
Explore the profile of Renee de Waal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Global trends in CD4 count measurement and distribution at first antiretroviral treatment initiation
de Waal R, Wools-Kaloustian K, Brazier E, Althoff K, Jaquet A, Duda S, et al.
Clin Infect Dis
. 2024 Nov;
PMID: 39501773
Background: While people with HIV (PWH) start antiretroviral treatment (ART) regardless of CD4 count, CD4 measurement remains crucial for detecting advanced HIV disease and evaluating ART programmes. We explored CD4...
2.
Plaisy M, Minga A, Wandeler G, Murenzi G, Samala N, Ross J, et al.
J Int AIDS Soc
. 2024 Apr;
27(4):e26238.
PMID: 38566493
Introduction: Liver disease is a leading cause of morbidity and mortality among persons living with HIV (PLHIV). While chronic viral hepatitis has been extensively studied in low- and middle-income countries...
3.
Phillips T, Kassanjee R, Maxwell N, Anderson K, Johnson L, Moolla H, et al.
J Int AIDS Soc
. 2024 Apr;
27(4):e26236.
PMID: 38566482
Introduction: In recent years, the expansion of HIV treatment eligibility has resulted in an increase in people with antiretroviral therapy (ART) experience prior to pregnancy but little is known about...
4.
Kebede S, Brazier E, Freeman A, Muwonge T, Choi J, de Waal R, et al.
AIDS
. 2023 Dec;
38(5):751-756.
PMID: 38133656
Background: While recognized as a key HIV prevention strategy, preexposure prophylaxis (PrEP) availability and accessibility are not well documented globally. We aimed to describe PrEP drug registration status and the...
5.
de Waal R, Rabie H, Technau K, Eley B, Sipambo N, Cotton M, et al.
Antivir Ther
. 2023 Apr;
28(2):13596535231168480.
PMID: 37038365
Background: WHO guidelines recommend abacavir in first-line antiretroviral treatment for children and neonates. However, there is no approved dose <3 months of age, and data in neonates are limited. Methods:...
6.
Romo M, Brazier E, Mahambou-Nsonde D, de Waal R, Sekaggya-Wiltshire C, Chimbetete C, et al.
J Int AIDS Soc
. 2022 Jul;
25(7):e25961.
PMID: 35848120
Introduction: Dolutegravir is being scaled up globally as part of antiretroviral therapy (ART), but for people with HIV and tuberculosis co-infection, its use is complicated by a drug-drug interaction with...
7.
van der Hoven J, Allen E, Cois A, de Waal R, Maartens G, Myer L, et al.
BMC Pregnancy Childbirth
. 2022 Jun;
22(1):466.
PMID: 35658841
Background: In the absence of clinical trials, data on the safety of medicine exposures in pregnancy are dependent on observational studies conducted after the agent has been licensed for use....
8.
Mouton J, Fortuin-de Smidt M, Jobanputra N, Mehta U, Stewart A, de Waal R, et al.
BMC Pediatr
. 2020 Jan;
20(1):3.
PMID: 31901244
Background: The high HIV prevalence in South Africa may potentially be shaping the local adverse drug reaction (ADR) burden. We aimed to describe the prevalence and characteristics of serious ADRs...
9.
Kalk E, Heekes A, Mehta U, de Waal R, Jacob N, Cohen K, et al.
Clin Infect Dis
. 2020 Jan;
71(8):e351-e358.
PMID: 31900473
Background: Isoniazid preventive therapy (IPT) is widely used to protect against tuberculosis (TB) in people living with human immunodeficiency virus (HIV). Data on the safety and efficacy of IPT in...
10.
de Waal R, Lessells R, Hauser A, Kouyos R, Davies M, Egger M, et al.
J Virus Erad
. 2018 Dec;
4(Suppl 2):55-58.
PMID: 30515315
The prevalence of pretreatment resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) is >10% in many low-income countries. As a consequence, several sub-Saharan African countries have implemented, or are considering the...